PRRT2 and acute myeloid leukemia: Treatment of AML cell lines with AraC, FLT3-inhibitors (midostaurin, PKC and quizartinib, AC220), and VEN in combination with lower dose of metformin significantly increased drug induced apoptosis in all AML models (Fig. 3k–l and supplementary Fig. 3j).